Correction to: Hepatocyte growth factor administration increases bone soluble phosphate and alters bone chemical structure in diabetic hypertensive rats

Hepatocyte growth factor (HGF) is a novel potential therapy for improving bone health in patients with type II diabetes and hypertension, but its effect on the molecular structure not revealed yet. Here, X-ray absorption near edge (XANES) spectroscopy was used to explore effects elicited by HGF chemical structure. This study assessed local calcium (Ca) phosphorus (P) coordination of diabetic hypertensive rat bones, each without treatment. Results that has significant Ca P chemistry as confirmed presence more soluble phosphates HGT-treated groups. Data indicated treated bones have poorly developed phosphate evidenced drastic drop post-edge shoulder L2, 3-edge compared control bone. Presence P, products resorption, treatment suggests unbalanced resorption formation.